BioCardia, Inc. - Common Stock, par value $0.001 per share (BCDA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
BCDA on Nasdaq
Shares outstanding
11,165,912
Price per share
$1.27
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
427,093
Total reported value
$551,879
% of total 13F portfolios
0%
Share change
+122,749
Value change
+$144,113
Number of holders
18
Price from insider filings
$1.27
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioCardia, Inc. - Common Stock, par value $0.001 per share (BCDA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lincoln Alternative Strategies LLC 7.5% $1,560,000 800,000 Lincoln Alternative Strategies LLC 19 Sep 2025
SATTERFIELD THOMAS A JR 9.9% +21% $1,356,010 +$467,153 592,144 +53% Thomas A. Satterfield, Jr. 30 Jun 2025
INTRACOASTAL CAPITAL, LLC 5% $1,086,499 557,179 Mitchell P. Kopin 18 Sep 2025
Blank Andrew Scott 5.5% $848,672 278,253 Blank Andrew Scott 23 Apr 2025

As of 30 Sep 2025, 18 institutional investors reported holding 427,093 shares of BioCardia, Inc. - Common Stock, par value $0.001 per share (BCDA). This represents 3.8% of the company’s total 11,165,912 outstanding shares.

Institutional Holders of BioCardia, Inc. - Common Stock, par value $0.001 per share (BCDA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 20,000 $25,400 +$3,810 $1.27 1
2025 Q3 427,093 $551,879 +$144,113 $1.29 18
2025 Q2 304,344 $593,207 +$114,077 $1.95 16
2025 Q1 245,413 $623,766 +$308,212 $2.54 12
2024 Q4 124,849 $272,169 +$50,907 $2.18 13
2024 Q3 101,482 $316,622 +$81,316 $3.12 9
2024 Q2 75,419 $223,995 +$223,995 $2.97 8